NewslettersDermal Cell NewsUncategorizedMetformin-Induced ROS Upregulation as Amplified by Apigenin Causes Profound Anticancer Activity While Sparing Normal CellsBy Justin.choi - July 13, 2021016Metformin combined with apigenin increased ROS levels dramatically and decreased cell viability in various cancer cells including AsPC-1 cells, with each drug used singly having a minimal effect.[Scientific Reports] 6445212 CMGKQKM3 items 1 apa 0 default asc 1 164500 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article